1. Home
  2. ARBEW vs CERT Comparison

ARBEW vs CERT Comparison

Compare ARBEW & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd. Warrant

ARBEW

Arbe Robotics Ltd. Warrant

N/A

Current Price

$0.12

Market Cap

0.0

Sector

Technology

ML Signal

N/A

CERT

Certara Inc.

HOLD

Current Price

$9.12

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBEW
CERT
Founded
2015
2008
Country
Israel
United States
Employees
144
N/A
Industry
EDP Services
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ARBEW
CERT
Price
$0.12
$9.12
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$13.25
AVG Volume (30 Days)
32.4K
2.4M
Earning Date
03-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$768,000.00
$415,551,000.00
Revenue This Year
N/A
$10.82
Revenue Next Year
N/A
$6.77
P/E Ratio
N/A
$134.09
Revenue Growth
N/A
11.47
52 Week Low
$0.13
$8.03
52 Week High
$1.25
$15.69

Technical Indicators

Market Signals
Indicator
ARBEW
CERT
Relative Strength Index (RSI) 32.50 47.95
Support Level $0.13 $8.42
Resistance Level $0.24 $9.17
Average True Range (ATR) 0.03 0.39
MACD -0.00 0.08
Stochastic Oscillator 10.61 53.60

Price Performance

Historical Comparison
ARBEW
CERT

About ARBEW Arbe Robotics Ltd. Warrant

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: